SSPL Securities Private Limited

Wednesday 25 Jun, 2025 11:16 PM

Nifty June futures trade at premium Reliance Infra hits the roof after bagging Rs 600-cr export order from Rheinmetall Exicom Tele-Systems jumps on fundraise plan, loan-to-equity conversion in EV subsidiary Garden Reach Shipbuilders & Engineers Ltd leads losers in 'A' group Adani Total Gas gains on joining hands with Jio-bp to enhance auto fuel retail experience in India Digitide Solutions Ltd leads losers in 'B' group Volumes spurt at Network 18 Media & Investments Ltd counter Lupin receives USFDA approval for generic Prucalopride tablets Radico Khaitan Ltd gains for third straight session Acme Solar's subsidiary signs 25-year PPA with SECI for 300 MW at Rs 3.05/kWh Aurobindo Pharma gets UK MHRA approval for neutropenia treatment drug Dyrupeg D B Corp Ltd spurts 1.36%, rises for fifth straight session JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets Global Vectra Helicorp Ltd leads gainers in 'B' group Mahanagar Telephone Nigam Ltd leads gainers in 'A' group

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets

25-Jun-25 12:22 Hrs IST

The approved dosages'10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg'are indicated for the treatment of symptoms of depression. Amitriptyline Hydrochloride is a tricyclic antidepressant widely prescribed for managing major depressive disorders.

JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates.

The company's consolidated net profit rose 15.5% to Rs 145.69 crore on a 10.2% rise in revenue to Rs 949.48 crore in Q4 FY25, compared with Q4 FY24.

Shares of JB Chemicals & Pharmaceuticals rose 0.10% to Rs 1,800.60 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 42203197

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)